Daewoong Co., Ltd. 003090.KS

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-02 · statements 2025-12-31

Average Intrinsic Value
$2.39B
Market Cap
$487.66M
Margin of Safety
79.6%
Intrinsic / Market Ratio
4.91

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

3.76B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

2.20B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.22B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

2.39B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

2.39B USD

from the sum above

Market Cap

487.66M USD

today's price times the shares

Intrinsic Value ÷ Market Cap

4.91×

the ratio the screener ranks by; Margin of Safety +79.6% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 3.76B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)4.20B USD
−②Net Debt Today441.29M USD
+③Growth Value0 USD
=Value3.76B USD

EPV of the Operations (NOPAT over WACC)

4.20B USD

Net debt today

-441.29M USD

Growth Value

0 USD

Value

3.76B USD

①EPV (earnings power value)

4.20B USD

②Net Debt Today

441.29M USD

③Growth Value

0 USD

Market value

Market Cap487.66M USD

Today's price times the shares.

Value vs market

Margin of Safety+87.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 2.20B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE924.69M USD
+②Equity at Year 15, Today1.28B USD
=Value2.20B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

924.69M USD

②Equity at Year 15, Today

1.28B USD

Market value

Market Cap487.66M USD

Today's price times the shares.

Value vs market

Margin of Safety+77.9%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.22B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an FCFF at or below zero in the latest three years), so the value is the book value today, 1.22B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Debt Today

Not in the value

Market value

Market Cap487.66M USD

Today's price times the shares.

Value vs market

Margin of Safety+60.0%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 3.50%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.28×Market Risk Premium 6.00%= 6.18%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 10.94M USDPretax Income 169.59M USD= 6.45%

The tax the interest saves.

Interest Expense =EBIT 179.25M USD−Pretax Income 169.59M USD= 9.65M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 9.65M USDTotal Debt 632.68M USD×(1 − Tax Rate for WACC 6.45%)= 1.43%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 632.68M USDMarket Cap + Total Debt 487.66M USD + 632.68M USD= 56.47%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 43.53%×Cost of Equity 6.18%+Debt Weight 56.47%×Cost of Debt 1.43%= 3.50%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 2.26B USD − Total Liabilities 1.04B USD = Book Value Today 1.22B USD

Total Debt 632.68M USD − Cash and Short-Term Investments 191.39M USD = Net Debt Today 441.29M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 12.8%at most 5%passes42,036,875 / 40,890,710
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.5%at least -10.0%passes(179.31M USD − 121.87M USD) ÷ 2.26B USD
Price to bookMarket Cap ÷ Book Value Today0.40×at most 3×passes487.66M USD ÷ 1.22B USD
Operating marginOperating Income ÷ Revenue12.7%above 10.0%passes182.25M USD ÷ 1.44B USD
Revenue growthRevenue ÷ Revenue a Year Before − 19.0%above 10.0%does not pass1.44B USD / 1.32B USD
Net cash(Cash − Total Debt) ÷ Market Cap-94.1%above -30%does not pass(173.87M USD − 632.68M USD) ÷ 487.66M USD
Operating efficiencyOperating Income ÷ Gross Profit23.7%above 25.0%does not pass182.25M USD ÷ 768.04M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

15.36K USD

Enterprise value

1.95T USD

market cap plus net debt

EV / EBITDA

6.07×

Price / book

—

the provider's book

Price / earnings

—

Return on equity

12.9%

the provider's, not the engine's

Profit margin

8.5%

Revenue growth

8.0%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

1.35B1.42B1.32B1.44B

Gross profit

714.58M729.50M715.54M768.04M

Operating income

164.68M153.23M192.31M182.25M

EBITDA

operating income before depreciation and amortisation

168.04M212.08M124.24M223.02M

Pretax income

123.06M158.65M78.98M169.59M

Net income

81.47M119.59M39.49M121.87M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

89.45M118.39M64.82M138.98M

R&D

134.94M138.34M120.09M129.98M
Balance sheet, year end

Total assets

1.71B1.85B1.86B2.25B

Total liabilities

698.50M722.63M831.01M1.02B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

658.32M732.28M679.78M819.12M

Total debt

353.56M351.61M465.68M611.37M

Cash and equivalents

151.26M126.66M130.65M178.16M

Net PP&E

fixed assets after depreciation

494.33M573.61M667.41M816.33M

Working capital

current assets less current liabilities

348.09M112.12M162.07M182.83M
Cash flow

Operating cash flow

118.41M161.10M110.77M179.31M

Capital expenditure

paid out, so below zero

-93.43M-179.35M-229.42M-242.23M

Depreciation and amortisation

38.35M42.47M40.10M43.78M

Free cash flow

operating cash flow plus capital expenditure

24.99M-18.25M-118.64M-62.91M